drugset / Trial / NCT05939167
Mesenchymal Stem Cells Treatment for AIDS Patients at Late Stage
Phase 1/2
Recruiting
150 enrolled
Cell Energy Life Sciences Group Co. LTD
Beijing 302 Hospital · collabBeijing YouAn Hospital · collabFifth Hospital of Shijiazhuang City · collabShenzhen Third People's Hospital · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The goal of this study is to conduct a prospective, double-blind, randomized placebo-controlled clinical trial to investigate the safety and efficacy of mesenchymal stem cells treatment for AIDS patients at late stage.
Timeline
- Start
- 2023-12-10
- Primary completion
- 2027-07-10
- Completion
- 2028-07-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mesenchymal stem cell | Cell therapy | 750000 cells/kg | Intravenous |
| Subject | Mesenchymal stem cell | Cell therapy | 1e+06 cells/kg | Intravenous |